Bone-seeking radiopharmaceuticals in patients with skeletal metastases. Clinical experience using alpha-emitting radium-223

被引：0
|
作者：
Nilsson, S.
Larsen, R. H.
Bruland, O. S.
机构：
[1] Karolinska Hosp, S-10401 Stockholm, Sweden
[2] Algeta ASA, Oslo, Norway
[3] Norwegian Radium Hosp, Oslo, Norway
来源：
RADIOTHERAPY AND ONCOLOGY | 2006年 / 78卷
关键词：
D O I：
10.1016/S0167-8140(06)80562-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
68
引用
收藏
页码：S23 / S24
页数：2
相关论文
共 50 条
  • [31] Clinical Experience and Radiation Safety of the First-in-Class Alpha-Pharmaceutical, Alpharadin (radium-223) in Patients with Castration-Resistant Prostate Cancer (CRPC) and Bone Metastases
    Nilsson, S.
    Parker, C.
    Biggin, C.
    Bruland, O.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S375 - S376
  • [32] RADIUM-223 DICHLORIDE (RADIUM-223) FOR THE TREATMENT OF PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER AND SYMPTOMATIC BONE METASTASES: THE ESSENTIAL ROLE OF NURSES IN PATIENT CARE AND MANAGEMENT
    Curley, Tracy
    Arauz, Gabrielle
    Jensen, Trine
    Wahba, Mona
    Delacruz, Anthony
    ONCOLOGY NURSING FORUM, 2014, 41 (02) : E115 - E115
  • [33] Re-treatment with radium-223: An international, prospective, open-label study in patients with castration-resistant prostate cancer and bone metastases.
    Sartor, A. Oliver
    Heinrich, Daniel
    Mariados, Neil
    Mendez-Vidal, Maria Jose
    Keizman, Daniel
    Thellenberg-Karlsson, Camilla
    Peer, Avivit
    Procopio, Giuseppe
    Frank, Stephen Jay
    Pulkkanen, Kalevi
    Rosenbaum, Eli
    Severi, Stefano
    Perez, Jose Manuel Trigo
    Schwarzenberger, Paul
    Li, Rui
    Nordquist, Luke T.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [34] Radium-223 dichloride treatment for prostate cancer with bone metastases: A symptomatic outcome review of 12 months experience
    Lee, H. H.
    McAddy, N. C.
    O'Sullivan, P.
    Crawley, P.
    Beesley, S.
    Naji, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S214 - S215
  • [35] Phase II clinical study of radium-223 chloride (BAY 88-8223) in Japanese patients with symptomatic castration-resistant prostate cancer (CRPC) with bone metastases.
    Uemura, Hiroji
    Nagamori, Satoshi
    Wakumoto, Yoshiaki
    Uemura, Hirotsugu
    Kimura, Go
    Yokomizo, Akira
    Kikukawa, Hiroaki
    Mizokami, Atsushi
    Kosaka, Takeo
    Masumori, Naoya
    Kawasaki, Yoshihide
    Yonese, Junji
    Nasu, Yasutomo
    Fukasawa, Satoshi
    Sugiyama, Takayuki
    Uemura, Motohide
    Yamaguchi, Iku
    Tsutsui, Hirokazu
    Matsunaga, Eisuke
    Matsubara, Nobuaki
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [36] 223Ra-dichloride SPECT and planar quantitative images for targeted alpha-emitting therapy of bone metastases
    Benabdallah, N.
    Bernardini, M.
    de Labriolle-Vaylet, C.
    Franck, D.
    Desbree, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S396 - S396
  • [37] The Role of Bone-Seeking Radionuclides in the Palliative Treatment of Patients With Painful Osteoblastic Skeletal Metastases
    Tomblyn, Michael
    CANCER CONTROL, 2012, 19 (02) : 137 - 144
  • [38] Optimization of Imaging Following 223Ra Administration in Targeted Alpha-Emitting Radionuclide Therapy of Bone Metastases
    Benabdallah, N.
    Bernardini, M.
    Desbree, A.
    de Labriolle-Vaylet, C.
    Franck, D.
    MEDICAL PHYSICS, 2015, 42 (06) : 3471 - 3471
  • [39] Optimization of imaging following 223Ra administration in targeted alpha-emitting radionuclide therapy of bone metastases
    Benabdallah, N.
    Bernardini, M.
    Vaylet, C. de Labriolle
    Franck, D.
    Desbree, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S56 - S57
  • [40] Quantitative imaging of 223Ra-chloride (Alpharadin) for targeted alpha-emitting radionuclide therapy of bone metastases
    Hindorf, Cecilia
    Chittenden, Sarah
    Aksnes, Anne-Kirsti
    Parker, Chris
    Flux, Glenn D.
    NUCLEAR MEDICINE COMMUNICATIONS, 2012, 33 (07) : 726 - 732
12345